ARTV
NASDAQ · Biotechnology
Artiva Biotherapeutics Inc
$9.78
-0.90 (-8.43%)
Open$10.60
Previous Close$10.68
Day High$10.70
Day Low$9.60
52W High$14.53
52W Low$1.47
Volume—
Avg Volume844.2K
Market Cap263.97M
P/E Ratio—
EPS$-3.43
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
-16.8% upside
Current
$9.78
$9.78
Target
$8.14
$8.14
$7.28
$8.14 avg
$10.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 567.1K | 1.13M | 14.43M |
| Net Income | -147,662,558 | -265,527,077 | -2,421,627 |
| Profit Margin | -26,045.0% | -24,742.8% | -16.8% |
| EBITDA | -154,251,730 | -292,785,501 | -2,990,686 |
| Free Cash Flow | — | — | -1,604,262 |
| Rev Growth | -50.0% | -50.0% | +14.0% |
| Debt/Equity | 0.00 | 0.00 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |